Yalçın, ŞuayibGümüş, MahmutÖksüzoğlu, BernaÖzdemir, FeyyazSarıoğlu, Aysugül AlptekinŞahin, BerksoyMandel, Nil MolinasGöker, Erdem2023-06-152023-06-152019-11Yalçın, S. vd. (2019). ''Nutritional aspect of cancer care in medical oncology patients''. Clinical Therapeutics, 41(11), 2382-2396.0149-29181879-114Xhttps://doi.org/10.1016/j.clinthera.2019.09.006https://www.sciencedirect.com/science/article/pii/S0149291819304837http://hdl.handle.net/11452/33040Purpose: Awareness of advances in the nutritional aspects of cancer care and translation of this information into clinical practice are important for oncology practitioners to effectively couple oncologic and nutritional approaches throughout the cancer journey. The goal of this consensus statement by a panel of medical oncologists was to provide practical and implementable guidance addressing nutritional aspects of cancer care from the perspective of the medical oncologist. Methods: A panel of medical oncologists agreed on a series of statements supported by scientific evidence and expert clinical opinion. Findings: Participating experts emphasized that both poor nutritional intake and metabolic alterations underlie cancer-related malnutrition. The use of liquid and high energy-dense oral nutritional supplements may enable better patient compliance, whereas higher efficacy is more likely with the use of pharmaconutrient-enriched oral nutritional supplements in terms of improved weight, lean body mass, functional status, and quality of life, as well as better tolerance to antineoplastic treatment. A multimodal approach is currently believed to be the best option to counteract the catabolism leading to cancer-related malnutrition; this treatment is scheduled in parallel with anticancer therapies and includes nutritional interventions, multitarget drug therapies, and exercise and rehabilitation programs. Participating experts emphasized the role of the oncologist as a reference professional figure in the coordination of nutritional care for patients with cancer within the context of complex and different clinical scenarios, particularly for permissive-adjunctive nutritional support.eninfo:eu-repo/semantics/openAccessPharmacology & pharmacyCancer cachexiaCancer patientsNutritional screeningNutritional supportMedical oncologist's perspectiveTreatmentPreoperative oral supplementationVitamin-DEIcosapentaenoic acidWeight-lossCachexiaMalnutritionGlutamineRiskExerciseTherapyConsensusExerciseHumansMalnutritionMedical OncologyNeoplasmsArticle0005031077000162-s2.0-8507489253823822396411131699437Pharmacology & pharmacyCachexia; Skeletal Muscle; Muscle AtrophyAmino acidAntineoplastic agentArginineBeta hydroxy beta methylbutyrateGlutamineNutrition supplementOmega 3 fatty acidTrace elementUnclassified drugBody massCachexiaCancer chemotherapyCancer patientDietary intakeExerciseFunctional statusHumanMacronutrientMalignant neoplasmMalnutritionMedical oncologistNutritionNutritional counselingNutritional requirementNutritional supportOncologistOncologyPathophysiologyPatient carePatient compliancePatient monitoringPhysician attitudeQuality of lifeReviewScreeningComplicationConsensusMalnutritionNeoplasmOncology